Barclays »

Viking Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $16M 196k 81.99
2023-12-31 $10M 540k 18.61
2023-09-30 $5.8M 522k 11.07
2023-06-30 $3.1M 189k 16.21
2023-03-31 $3.0M 181k 16.65
2022-12-31 $359k 38k 9.39
2022-09-30 $11k 4.0k 2.73
2022-06-30 $0 1 0.00
2022-03-31 $35k 11k 3.06
2021-12-31 $382k 83k 4.60
2021-09-30 $180k 29k 6.31
2021-06-30 $57k 9.5k 5.97
2021-03-31 $517k 82k 6.32
2020-12-31 $303k 54k 5.62
2020-09-30 $430k 74k 5.81
2020-06-30 $850k 118k 7.21
2020-03-31 $359k 77k 4.67
2019-12-31 $635k 79k 8.02
2019-09-30 $234k 34k 6.88
2019-06-30 $519k 63k 8.29
2019-03-31 $172k 17k 9.96
2018-12-31 $89k 12k 7.64
2018-09-30 $7.4M 427k 17.44
2018-06-30 $2.2M 239k 9.39
2018-03-31 $64k 15k 4.39
2017-12-31 $7.0k 1.7k 4.15